本文選題：兒童藥品 + 短缺��； 參考：《中國藥房》2017年33期

【摘要】：目的:為提高兒童藥品的供應保障水平提供參考。方法:對江蘇省內13家三級醫(yī)院的兒童藥品短缺情況及原因等進行問卷調查[主要面向各受訪醫(yī)院的藥學部主任(或藥品采購人員)和臨床藥師],并就調查數(shù)據進行統(tǒng)計和分析,進而提出建議。結果:共發(fā)放問卷26份,回收有效問卷26份,有效回收率為100%。13家受訪醫(yī)院兒童專用藥品在各自醫(yī)院藥品目錄中的占比多數(shù)5%;共有82個兒童專用藥品品種(含醫(yī)院制劑),主要的3類為中成藥(35.37%)、呼吸系統(tǒng)用藥(12.20%),以及維生素、礦物質和腸內腸外營養(yǎng)藥(10.98%)。在126種短缺兒童藥品中,抗感染藥物、抗腫瘤藥物、神經系統(tǒng)用藥和精神藥物、消化系統(tǒng)用藥短缺品種最多(均占8.73%)。在兒童藥品的短缺原因方面,價格因素(38.10%)、廠家停產(32.54%)及未中標或無供應(13.49%)等為主要原因;價格在0.01~10.00元的低價藥品短缺情況最為嚴重,占全部短缺品種的57.94%。受訪者認為�？朴盟幎倘睂εR床治療的影響最大(38.46%),其次為解毒藥(30.77%)和罕見病治療藥(15.38%)。結論:兒童專用藥品在醫(yī)院藥品目錄中占比很小,兒童藥品短缺受到多種因素影響,且低價藥品短缺情況尤其嚴重,兒童�？朴盟幒徒舛舅幍亩倘北徽J為對臨床治療的影響較大。建議通過制定兒童專用藥品保護性政策,改進藥品流通環(huán)節(jié),促進兒童藥物臨床試驗開展及加強兒童專用藥品研發(fā)等措施保障兒童藥品的供應。
[Abstract]:Objective: to provide reference for improving the supply and security level of children's drugs. Methods: a questionnaire survey was conducted on the situation and causes of children's drug shortage in 13 tertiary hospitals in Jiangsu Province [mainly for pharmaceutical department directors (or drug purchasers) and clinical pharmacists in the hospitals interviewed], and the survey data were analyzed. Conduct statistics and analysis, And then put forward suggestions. Results: 26 questionnaires were distributed and 26 valid questionnaires were collected. The effective recovery rate was 100. 13 hospitals. The proportion of children's drugs in the list of medicines for children in their respective hospitals was 5 percent; there were 82 varieties of drugs for children (including hospital preparations, the main three categories were Chinese patent medicine (TCD) 35.37D, respiratory medicine was 12.20%), and vitamins, Minerals and parenteral nutrition 10.98%. Among 126 kinds of drugs for children, antiinfective drugs, antineoplastic drugs, nervous system drugs and psychotropic drugs, and digestive system drugs were the most common drugs (8.73%). In terms of the reasons for the shortage of children's drugs, the price factor is 38.10%, the manufacturer stops producing 32.54 parts) and the price is not awarded or no supply is 13.49%), and the low price medicine with price of 0.01 or 10.00 yuan is the most serious one, accounting for 57.94% of the total shortage varieties. The interviewees thought that the shortage of specialized drugs had the greatest effect on clinical treatment, followed by detoxification drug 30.77) and rare disease treatment drug 15.38%. Conclusion: the proportion of special drugs for children in the list of hospital drugs is very small. The shortage of children's drugs is affected by many factors, and the shortage of low price drugs is especially serious. Specialized drugs for children and a shortage of poisons are considered to have a greater impact on clinical treatment. It is suggested that some measures should be taken to ensure the supply of children's drugs, such as making protective policies for children's special drugs, improving the circulation of drugs, promoting the development of clinical trials of children's drugs and strengthening the research and development of children's special drugs.
【作者單位】： 南京醫(yī)科大學附屬兒童醫(yī)院;
【基金】：江蘇省衛(wèi)計委藥物政策研究課題(No.蘇衛(wèi)辦藥政[2016]5號)
【分類號】：R95

【相似文獻】

相關期刊論文 前10條

1 方曙，盛炳義，，江海碧;我國兒童藥品生產應用的現(xiàn)狀和建議[J];中國藥事;1995年03期

2 劉強;;我國兒童藥品存在問題分析及建議[J];臨床合理用藥雜志;2012年27期

3 何淑旺;邱瓊;;歐盟兒童藥品管理的經驗及啟示[J];中國藥物評價;2013年05期

4 國學瑞;;陜西省兒童藥品及醫(yī)療器械發(fā)展之我見[J];西北藥學雜志;1986年04期

5 孫笑寒;;兒童藥品包裝設計的人文關懷[J];遼寧工業(yè)大學學報(自然科學版);2013年02期

6 ;專家呼吁兒童藥審批亟待專門化[J];臨床合理用藥雜志;2013年20期

7 王文雪;劉p

本文編號：1891052